Fine Mark National Bank & Trust Pfizer Inc Transaction History

Fine Mark National Bank & Trust

$2.84 Billion
Q3 2024

A detailed history of Fine Mark National Bank & Trust transactions in Pfizer Inc stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 211,998 shares of PFE stock, worth $5.59 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

211,998

Previous 216,967 2.29%

Holding current value

$5.59 Million

Previous $6.07 Million 1.07%

% of portfolio

0.22%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $137,641 - $155,976	-4,969 Reduced 2.29%	211,998 $6.14 Million
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $896,098 - $1.05 Million	-35,475 Reduced 14.05%	216,967 $6.07 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $492,350 - $565,375	-19,017 Reduced 7.01%	252,442 $7.01 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $492,759 - $640,040	-18,858 Reduced 6.5%	271,459 $7.82 Million
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $572,325 - $668,990	-17,835 Reduced 5.79%	290,317 $9.63 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $7,079 - $8,190	-196 Reduced 0.06%	308,152 $11.3 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $19,064 - $24,819	484 Added 0.16%	308,348 $12.6 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $849,111 - $1.11 Million	-20,338 Reduced 6.2%	307,864 $15.8 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $258,621 - $315,712	-5,910 Reduced 1.77%	328,202 $14.4 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $268,664 - $318,551	-5,774 Reduced 1.7%	334,112 $17.5 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $4.02 Million - $4.98 Million	-87,760 Reduced 20.52%	339,886 $17.6 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $41,857 - $62,046	-1,013 Reduced 0.24%	427,646 $25.3 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $73,201 - $94,033	-1,865 Reduced 0.43%	428,659 $18.4 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $30,092 - $34,089	-838 Reduced 0.19%	430,524 $16.9 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $67,080 - $75,653	-2,003 Reduced 0.46%	431,362 $15.6 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $225,955 - $287,322	-6,751 Reduced 1.53%	433,365 $16 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $16,414 - $19,258	-517 Reduced 0.12%	440,116 $16.2 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $77,559 - $94,090	2,575 Added 0.59%	440,633 $14.4 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $183,236 - $261,804	6,779 Added 1.57%	438,058 $14.3 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $314,912 - $357,385	9,566 Added 2.27%	431,279 $16.9 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $37,103 - $48,112	1,142 Added 0.27%	421,713 $14.4 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $528,592 - $593,486	14,294 Added 3.52%	420,571 $18.2 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $418,162 - $459,421	-11,151 Reduced 2.67%	406,277 $17.3 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $202,736 - $231,142	5,270 Added 1.28%	417,428 $18.2 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $498,022 - $604,070	-14,448 Reduced 3.39%	412,158 $18.2 Million
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $331,119 - $353,006	10,040 Added 2.41%	426,606 $15.5 Million
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $192,513 - $223,341	6,033 Added 1.47%	416,566 $14.8 Million
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $214,227 - $227,302	6,441 Added 1.59%	410,533 $14.9 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $12.5 Million - $13.8 Million	404,092	404,092 $14.4 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Account

Fine Mark National Bank & Trust Pfizer Inc Transaction History